Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Leukemia ; 36(12): 2853-2862, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36241696

RESUMO

Risk-stratified treatment strategies have the potential to increase survival and lower toxicity in relapsed/refractory classical Hodgkin lymphoma (R/R cHL) patients. This study investigated the prognostic value of serum (s)TARC, vitamin D and lactate dehydrogenase (LDH), TARC immunohistochemistry and quantitative PET parameters in 65 R/R cHL patients who were treated with brentuximab vedotin (BV) and DHAP followed by autologous stem-cell transplantation (ASCT) within the Transplant BRaVE study (NCT02280993). At a median follow-up of 40 months, the 3-year progression free survival (PFS) was 77% (95% CI: 67-88%) and the overall survival was 95% (90-100%). Significant adverse prognostic markers for progression were weak/negative TARC staining of Hodgkin Reed-Sternberg cells in the baseline biopsy, and a high standard uptake value (SUV)mean or SUVpeak on the baseline PET scan. After one cycle of BV-DHAP, sTARC levels were strongly associated with the risk of progression using a cutoff of 500 pg/ml. On the pre-ASCT PET scan, SUVpeak was highly prognostic for progression post-ASCT. Vitamin D, LDH and metabolic tumor volume had low prognostic value. In conclusion, we established the prognostic impact of sTARC, TARC staining, and quantitative PET parameters for R/R cHL, allowing the use of these parameters in prospective risk-stratified clinical trials. Trial registration: NCT02280993.


Assuntos
Doença de Hodgkin , Imunoconjugados , Humanos , Brentuximab Vedotin , Doença de Hodgkin/diagnóstico por imagem , Doença de Hodgkin/tratamento farmacológico , Prognóstico , Estudos Prospectivos , Transplante de Células-Tronco , Recidiva Local de Neoplasia/diagnóstico por imagem , Recidiva Local de Neoplasia/tratamento farmacológico , Imunoconjugados/uso terapêutico , Tomografia por Emissão de Pósitrons , Vitamina D/uso terapêutico
2.
BMC Med Res Methodol ; 11: 30, 2011 Mar 16.
Artigo em Inglês | MEDLINE | ID: mdl-21410979

RESUMO

BACKGROUND: This study aimed to evaluate the reliability and validity of two self-report physical activity (PA) questionnaires - the AQuAA (Activity Questionnaire for Adults and Adolescents) and PASE (Physical Activity Scale for the Elderly) - in cancer patients. METHODS: Test-retest reliability was determined by administering the questionnaires twice within 5 days. Intraclass correlation coefficient (ICC), standard error of measurement (SEM) and smallest detectable difference (SDD) were calculated. Construct validity was determined by comparing the questionnaire results with ActiGraph accelerometer scores using Spearman correlation coefficients (rs) and ICCs. Content validity was examined using the Three-Step Test-Interview (TSTI). RESULTS: Reliability for the AQuAA scores were fair to excellent (ICC = 0.57 to 0.78). Reliability for the PASE scores ranged from good to excellent (ICC = 0.67 to 0.90). Correlations between the ActiGraph and the AQuAA and the PASE were low (rs = 0.05 and 0.16 respectively, and ICC = -0.001 to 0.44). The TSTI showed that participants experienced difficulties with the examples provided with the questions, the perceptions of intensity level of PA, and with recalling the time spent on PA. CONCLUSIONS: Both questionnaires showed good to excellent test-retest reliability for most scores. Construct validity of both questionnaires was low, as indicated by the low correlations with the ActiGraph. Except for a few difficulties that participants perceived when filling out the questionnaires, the content validity of both questionnaires was good.


Assuntos
Atividade Motora , Neoplasias/psicologia , Aptidão Física , Inquéritos e Questionários , Adulto , Idoso , Exercício Físico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Psicometria , Reprodutibilidade dos Testes
3.
PLoS One ; 12(7): e0181313, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28727771

RESUMO

BACKGROUND: This single blind, multicenter randomized controlled trial aimed to evaluate the effectiveness of a supervised high intensity exercise program on physical fitness and fatigue in patients with multiple myeloma or lymphoma recently treated with autologous stem cell transplantation. METHODS: 109 patients were randomly assigned to the 18-week exercise intervention or the usual care control group. The primary outcomes included physical fitness (VO2peak and Wpeak determined using a cardiopulmonary exercise test; grip strength and the 30s chair stand test) and fatigue (Multidimensional Fatigue Inventory) and were assessed prior to randomization and after completion of the intervention or at similar time points for the control group. Multivariable multilevel linear regression analyses were performed to assess intervention effects. RESULTS: Patients in the intervention group attended 86% of the prescribed exercise sessions. Of the patients in the control group, 47% reported ≥10 physiotherapy sessions, which most likely included supervised exercise, suggesting a high rate of contamination. Median improvements in physical fitness ranged between 16 and 25% in the intervention group and between 12 and 19% in the control group. Fatigue decreased in both groups. There were no significant differences between the intervention and control group. CONCLUSION: We found no significant beneficial effects of the supervised high intensity exercise program on physical fitness and fatigue when compared to usual care. We hypothesized that the lack of significant intervention effects may relate to suboptimal timing of intervention delivery, contamination in the control group and/or suboptimal compliance to the prescribed exercise intervention. TRIAL REGISTRATION: Netherlands Trial Register-NTR2341.


Assuntos
Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/terapia , Terapia por Exercício , Treinamento Intervalado de Alta Intensidade , Aptidão Física , Adulto , Idoso , Feminino , Humanos , Linfoma/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Mieloma Múltiplo/tratamento farmacológico , Método Simples-Cego
4.
Cancer Treat Rev ; 35(2): 185-92, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19004560

RESUMO

PURPOSE: To summarize and define the methodological quality of primary research findings obtained in exercise interventions, aimed at improving physical function or psychological well-being in patients treated for haematological malignancies. METHODS: Relevant trials were identified through a computerized Mesh-search in MEDLINE and PubMed up to September 2007. Two reviewers independently screened the trials for eligibility, rated their quality, and extracted data. RESULTS: Ten studies published between 1996 and 2007 were included in this review. Two were performed in children and eight in adults. Only three studies were randomised controlled trials, one a controlled trial and the remaining six were single-group studies. Four trials were performed during treatment for cancer. The remainder was performed post-treatment. A wide variety of exercise protocols were applied, differing in exercise type, frequency, duration and intensity. Even though the trials were of poor methodological quality, encouraging results were obtained for a diverse set of outcomes, such as physical fitness, health-related quality of life and psychological well-being. CONCLUSION: Although none of the trials presented in this review are of high methodological quality, the findings suggest that it is feasible to conduct exercise interventions in this particular population of cancer patients. Future interventions should include larger study populations, use appropriate control groups, and a standard collection of valid outcome measures to improve comparability between studies.


Assuntos
Neoplasias Hematológicas/reabilitação , Modalidades de Fisioterapia , Ensaios Clínicos como Assunto , Humanos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa